Skip to main content
. 2017 Mar 15;58(3):665–667. doi: 10.3349/ymj.2017.58.3.665

Fig. 1. Peripheral blood, bone marrow section, and HBB sequencing analysis results. (A) Erythrocytosis (peripheral blood, Wright-Giemsa, ×400) and (B) normocellular marrow without myeloproliferative features are noted (hematoxylin and eosin stain, ×100). (C) DNA sequencing of hemoglobin beta gene identified a heterozygous mutation at position 310, resulting in replacement of a phenylalanine by a leucine residue [β103(G5)Phe→Leu, NM_000518.4:c.310T>C (p.Phe104Leu)]. The arrow indicates the 310th nucleotide. HBB, beta-globin gene.

Fig. 1